AI News Intelligence & Analysis
Colossal Biosciences aims to raise new capital, targeting a valuation between $20B and $30B. The de-extinction startup plans to double or triple its previous worth, showcasing its ambitious growth strategy. As interest in biotechnology and conservation increases, Colossal's innovative approach to de-extinction continues to attract attention from investors and the public alike.
⚖️ AI Verdict
"Looks like Colossal is aiming for the stars with its funding goals!"
Ask about this Intel File
File Opened for Analysis
Ask me anything about the event, its implications, or who is responsible for the SINS!